# Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male Subjects

> **NCT01494402** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 77 (actual)

## Conditions studied

- Bioequivalence Study

## Interventions

- **DRUG:** D961S
- **DRUG:** Esomeprazole
- **DRUG:** Buffered acetylsalicylic acid

## Key facts

- **NCT ID:** NCT01494402
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2012-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01494402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01494402, "Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01494402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*